REFERENCES
- von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsy-chopharmacol 2005; 15: 473–490
- Vanital lie TB. Parkinson disease: Primacy of age as a risk factor for mitochondrial dysfunction. Metabolism 2008; 57 (Suppl. 2): S50—S55
- Payami H, Zareparsi S. Genetic epidemiology of Parkinson's disease. Geriatr Psychiatry Neurol 1998; 11: 98–106
- Fukuda T. Neurotoxicity of MPTP. Neuropathology 2001; 21: 323-332
- Wichmann T, DeLong MR. Pathophysiology of Parkinson's disease: The MPTP primate model of the human disorder. Ann NY Acad Sci 2003; 991: 199–213
- Grünblatt E, Mandel S, Youdim M, et al. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomor-ph ine. J Neurochem 2001; 78: 1–12
- Youdim MB, Grünblatt E, Mandel S, et al. Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron. Neurotox Res 2002; 4: 679–689
- Lee H, Park Hi, Park J, et al. Acupuncture application for neurological disorders. Neurol Res 2007; 29 (Suppl. 1): 549—S54
- Liang XB, Liu XY, Li FQ, et a/. Long-term high frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Mol Brain Res 2002; 108: 51–59
- Guo JC, Gao HM, Chen J, et al. Modulation of the gene expression in the protective effects of electroacupuncture against cerebral ischemia: A cDNA microarray study. Acupunct Electrother Res 2004; 29: 173–86
- Shiue HS, Lee YS, Tsai CN, et al. DNA microarray analysis of the effect on inflammation in patients treated with acupuncture for allergic rhinitis. I Altem Complement Med 2008; 14: 689–698
- Ko J, Na DS, Lee YH, et al. cDNA microarray analysis of the differential gene expression in the neuropathic pain and electro-acupuncture treatment models. I Biochem Mol Biol 2002; 35: 420–427
- Jeon S, Kim YJ, Kim ST, et a/. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics 2008; 8: 4822–4832
- WHO Regional Office for the Western Pacific. WHO Standard Acupuncture Point Locations in the Western Pacific Region, Bernan: WHO Regional Office for the Western Pacific, 2008
- Hayley S, Crocker SJ, Shree T, et al. Regulation of dopaminergic loss by Fas in a 1-ethyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2004; 24: 2045–2053
- Yin CS, Jeong HS, Park HJ, et al. A proposed transpositional acupoint system in a mouse and rat model. Res Vet Sci 2008; 84: 159–165
- Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57
- Ren XM. Fifty cases of Parkinson's disease treated by acupuncture combined with madopar. I Tradit Chin Med 2008; 28: 255–257
- Wang X, Liang XB, Li FQ, et a/. Therapeutic strategies for Parkinson's disease: The ancient meets the future-traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res 2008; 33: 1956–1963
- Koutsilieri E, Riederer P. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease. Parkinsonism Relat Disord 2007; 13 (Suppl. 3): S329—S331
- Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol 2009; 8: 382–397
- Fuxe KG, Tarakanov AO, Goncharova LB, et al. A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 2008; 58: 453–458
- Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance. Ann NY Acad Sci 2008; 1147: 93–104